NMIMC
WST icon

Northwestern Mutual Investment Management Company’s West Pharmaceutical WST Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$577K Buy
2,302
+4
+0.2% +$995 0.01% 757
2025
Q4 		$632K Buy
2,298
+6
+0.3% +$1.64K 0.01% 730
2025
Q3 		$601K Hold
2,292
– – 0.01% 735
2025
Q2 		$501K Sell
2,292
-11
-0.5% -$2.35K 0.01% 767
2025
Q1 		$516K Buy
2,303
+2
+0.1% +$551 0.01% 763
2024
Q4 		$754K Buy
2,301
+3
+0.1% +$944 0.02% 657
2024
Q3 		$690K Sell
2,298
-20
-0.9% -$6.13K 0.02% 690
2024
Q2 		$764K Sell
2,318
-29
-1% -$10.2K 0.02% 632
2024
Q1 		$929K Buy
2,347
+5
+0.2% +$1.85K 0.02% 567
2023
Q4 		$825K Buy
2,342
+11
+0.5% +$3.89K 0.02% 597
2023
Q3 		$875K Sell
2,331
-11
-0.5% -$4.25K 0.02% 518
2023
Q2 		$896K Buy
2,342
+15
+0.6% +$5.36K 0.02% 537
2023
Q1 		$806K Buy
2,327
+7
+0.3% +$2.04K 0.02% 562
2022
Q4 		$546K Sell
2,320
-430
-16% -$102K 0.01% 458
2022
Q3 		$677K Sell
2,750
-211
-7% -$64.3K 0.02% 489
2022
Q2 		$895K Buy
2,961
+15
+0.5% +$4.88K 0.02% 421
2022
Q1 		$1.21M Sell
2,946
-723
-20% -$283K 0.03% 379
2021
Q4 		$1.72M Sell
3,669
-38
-1% -$16.4K 0.03% 282
2021
Q3 		$1.57M Buy
3,707
+354
+11% +$149K 0.03% 282
2021
Q2 		$1.2M Sell
3,353
-6
-0.2% -$1.98K 0.02% 382
2021
Q1 		$946K Sell
3,359
-699
-17% -$200K 0.02% 484
2020
Q4 		$1.15M Buy
4,058
+14
+0.3% +$3.93K 0.02% 573
2020
Q3 		$919K Hold
4,044
– – 0.01% 571
2020
Q2 		$919K Sell
4,044
-21,665
-84% -$4.26M 0.01% 572
2020
Q1 		$3.91M Buy
25,709
+4,576
+22% +$704K 0.06% 98
2019
Q4 		$3.18M Buy
21,133
+105
+0.5% +$15.3K 0.06% 119
2019
Q3 		$2.98M Buy
21,028
+70
+0.3% +$9.64K 0.07% 119
2019
Q2 		$2.62M Buy
20,958
+7,760
+59% +$916K 0.06% 136
2019
Q1 		$1.45M Sell
13,198
-805
-6% -$83.7K 0.03% 469
2018
Q4 		$1.37M Buy
14,003
+142
+1% +$15.4K 0.02% 471
2018
Q3 		$1.71M Sell
13,861
-601
-4% -$67.4K 0.03% 480
2018
Q2 		$1.44M Sell
14,462
-677
-4% -$62.3K 0.02% 531
2018
Q1 		$1.34M Buy
15,139
+5,414
+56% +$506K 0.02% 549
2017
Q4 		$960K Buy
9,725
+45
+0.5% +$4.41K 0.02% 538
2017
Q3 		$932K Sell
9,680
-2,981
-24% -$270K 0.02% 530
2017
Q2 		$1.2M Buy
12,661
+36
+0.3% +$3.31K 0.02% 532
2017
Q1 		$1.03M Buy
12,625
+13
+0.1% +$1.09K 0.02% 560
2016
Q4 		$1.07M Buy
12,612
+4
+0% +$315 0.02% 466
2016
Q3 		$939K Sell
12,608
-8
-0.1% -$635 0.02% 471
2016
Q2 		$957K Buy
12,616
+137
+1% +$9.97K 0.02% 296
2016
Q1 		$865K Buy
+12,479
New +$751K 0.02% 338

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northwestern Mutual Investment Management Company's WST Position: Q1 2026 in Review

Northwestern Mutual Investment Management Company increased its West Pharmaceutical (WST) stake by 0.17% in Q1 2026, buying an estimated $995 and bringing the position to 2,302 shares worth $577K. The position accounts for 0.01% of the portfolio, ranked #757.

Northwestern Mutual Investment Management Company first reported a position in WST in Q1 2016 and has held it in 41 quarters since. The position peaked at $3.91M in Q1 2020. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Northwestern Mutual Investment Management Company held 2,302 shares of West Pharmaceutical worth $577K as of Q1 2026.
  • Northwestern Mutual Investment Management Company bought 4 West Pharmaceutical shares in Q1 2026, an estimated $995.
  • West Pharmaceutical made up 0.01% of Northwestern Mutual Investment Management Company's portfolio in Q1 2026, its #757 holding.
  • Northwestern Mutual Investment Management Company first reported a position in West Pharmaceutical in Q1 2016 and has held it in 41 quarters since.
  • Northwestern Mutual Investment Management Company's West Pharmaceutical position peaked at $3.91M in Q1 2020.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q1 2026, filed 8 May 2026.